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ABSTRACT  The  mechanism  of  the  antitumor  action  of  polyinosinic-poly-
cytidylic  acid  is  probably  multifaceted.  The  compound  induces  the  synthesis
of interferon,  and  interferon  probably  is  active  against  some  tumors.  Poly  I:
poly  C  alters  protein  and  RNA  synthesis  in  tissue  culture.  It  specifically  in-
hibits  such  macromolecule  synthesis  in  tumors  in  vivo,  while  having  less  in-
hibitory  action  on  synthesis  in  normal  organs,  or  it  may  actually  enhance.
Finally,  poly I:poly  C  strongly enhances  graft vs.  host  rejection  mechanisms,
which  may  play  a  role  in  the  rejection  of some  tumors.
It  was originally  proposed  by Isaacs  that the interferon  response  is  induced
by the  presence  in  a  cell  of  a  foreign  nucleic  acid.  The  net  effect  of this
response  is,  in effect,  to reduce  the  damage brought  about  by the presence
of this foreign nucleic acid,  which usually would be viral nucleic acid.  Isaacs'
hypothesis  was supported  by  some data  showing  that  foreign  nucleic  acids
do  indeed  lead  to the  production  of  some slight  amount  of interferon.  His
data were not very convincing,  and general  acceptance  of this concept  was
held in  abeyance.  The validity of this  hypothesis  has recently  received  sup-
port  from  the findings  that  certain  double-stranded  synthetic  and  natural
ribonucleic acids, particularly polyinosinic-polycytidylic  acid (poly I :poly C),
can  lead  to  the  development  by  cells  of  a  high  level  of resistance  to virus
replication  and  to  the  production  of  large  amounts  of  interferon,  both  in
vivo and tissue culture  (7).
While interferon  itself is  in  general  not toxic  to animals  and does  not in-
hibit  cell  growth,  poly  I:poly  C  has been  found  to inhibit  the growth  of a
number  of  experimental  tumors  in  animals  (8,  9).  The  variety  of  tumors
affected  and  the  extent  of  inhibition  are  shown  in Table  I.  In  addition  to
those  shown,  carcinogenesis  by  dimethylbenzanthracene  (DMBA)  plus
croton  oil,  or by DMBA  alone,  is strongly inhibited  by suitable  administra-
tion  of poly I :poly C  (11).  This presentation  will discuss  this inhibition  and
the possible mechanism  of its action.
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TABLE  I
EFFECT  OF  POLY  I:C  ON ANIMAL  TUMORS
Increase in median
Tumor  survival  over control
J96132-Reticulum  cell sarcoma  (subcutaneous)  130*
J96132-Reticulum  cell sarcoma  (ascites)  96*
Carcinosarcoma  Walker  256  100
Reticulum cell  sarcoma RCSL  89
Ehrlich  ascites tumor  70
S91 Melanoma  55
Fibrosarcoma  52
IB1237-Lymphoma  (ascites)  45
]L1210  leukemia  42
Plasma cell YPC-1  39
B1237-Lymphoma  (subcutaneous)  28
MT-I  tumor  (subcutaneous)  26
Reticulum cell sarcoma  ovarian  20
Leukemia  P388  16
Leukemia  K1964  12
Treatment,  in  most  cases,  was  150-200  /ug per mouse,  three  times  weekly,  by  intraperitoneal
route.  With  the exception  of the J96132  reticulum  cell sarcoma,  some Ehrlich  ascites tumors,
and  a few Walker carcinosarcoma,  all animals ultimately died.
*  Mean day  of death of the animals that died.  About 30%  of all the animals treated have  sur-
vived,  although treatment had been stopped at about day 50
The mechanism  of action  of this compound appears  to be complex.  Viral
interference  (1),  interferon  (2),  and interferon  inducers  (3)  can inhibit  the
growth  of  oncogenic  viruses  in  tissue culture  (4)  and  can  alter  the  course
of murine leukemias  in  animals  (3,  5,  6,  10,  13).  It has been  clearly shown
by  Gresser  et  al.  that the  murine  leukemias,  such  as  those  induced  by  the
Friend virus (5),  are inhibited by exogenous  interferon.  Wheelock has shown
that the interferon inducer, statolon,  also inhibits the development of Friend
virus  leukemia  (3).  Cell  transformation  by  oncogenic  viruses  can  also  be
inhibited by interferon inducers  (12).  In addition Gresser  has shown that the
growth  of  a  dimethylbenzanthracene-induced  tumor  is  also  inhibited  by
interferon  (14),  as  shown  in  Fig.  1. In  the  animals  bearing  those  tumors
interferon  treatment  brought  about  an  increased  phagocytosis  of  tumor
cells.  The mechanism by which interferon  may inhibit the tumors will be re-
ferred to later. Since  poly I :poly C is a potent inducer of interferon in mice,
it is likely  that part of the  antitumor  action  of the double-stranded  RNA  is
through the interferon  system.
A second aspect of the activity of poly I :poly C may be as a direct chemo-
therapeutic  agent.  Poly  I:poly  C  is  a  double-stranded  RNA,  the  homo-
]polymers  of which  can  code  for  the synthesis  of  polypeptides  in  a suitable
cell-free  test system.  Poly  C,  for  example,  should  code  for  the synthesis  of
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FIGURE  1.  Increased  survival in C57 black  mice inoculated  i.p.  with EL4  tumor cells
and  treated  with  interferon preparations.  Figure adapted from C. R.  Hebd.  Seances  Acad.
Sci.  Paris, 1969, 268: 994, and reprinted  by  permission  from Gauthier-Villars,  Paris.
polyproline.  If  the  poly  C component  of the  poly  I:poly  C  were  to  be re-
sponsible  for  the synthesis  of polyproline  in  the cell  one might  imagine  any
number  of cellular  reactions  to  the  presence  of  this  "nonsense"  protein.
Poly  I:poly  C  does stimulate  the incorporation  of proline  into  the proteins
of L  cells,  but it also  stimulated  incorporation  of a number  of other  amino
acids  for which  it  should not  code.  Further,  polyadenylic-polyuridylic  acid
also  stimulated  proline  incorporation  for which it  should not  code.  Neither
nucleic  acid has  much  effect  on  phenylalanine  incorporation  for  which the
poly  U  would  code  (Fig.  2).  One  can  conclude  that  the  double-stranded
RNA's  do  stimulate  amino  acid  incorporation  into  proteins  but  are  not
acting  intracellularly  as  synthetic  messenger  RNA's.  The  nature  of  the
proteins made  is under study.
The  increased  amino  acid  incorporation  is  seen  also  in  animals.  Normal
C57 black mice were injected  intraperitoneally with  150  g of poly I :poly C,
the  same  dose  as  used  in  the  treatment  of the  tumor-bearing  mice.  16  hr
later  the animals  received  10  /cCi  of proline-1 4C  also  intraperitoneally.  2  hr
later the acid insoluble radioactivity  in a number of organs  was determined
and compared  with that found in  animals that had received  the radioactive
proline but no poly I :poly C. The results are summarized in Fig. 3.  One can
see  that  many  of  the  organs  showed  increased  rates  of  protein  synthesis.
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FIGuRE  2.  Effect  of  poly  I:poly C and poly A:poly  U  on amino  acid  incorpora-
tion  into  primary  mouse  embryo  cells.  Primary  mouse  embryo  cells  were  exposed
for  16  hr  to  100  ug/ml  of  the RNA  in  the presence  of  BME  and  5%  fetal  calf
serum.  The  medium  was  changed  to  BME  without  serum  for  1 hr,  and  then  the
cells were  exposed  to  the  labeled  amino  acid  for  30  sec.  Radioactivity  was  deter-
mined  on  the  acid  insoluble  portion  of  the  cells.
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FIGURE  3.  Effect  of poly I :poly  C  on proline incorporation  into various  organs of a
normal mouse.  Three C57 black mice were treated with 200 mug per mouse of poly I :poly
C, intraperitoneally.  Three  mice served  as  controls.  After  16 hr, the mice were exposed
to  10  uc  proline-14C  for  40  sec,  and  the  radioactivity incorporated  into acid  insoluble
components  of the  indicated  organs  was  measured.  Ordinate  is  specific  activity,  ex-
pressed as dpm  X  10-/mg protein.
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Additional  experiments  were  done  with  C57  black  Kaplan  strain  of  mice
bearing  the  J96132  reticulum  cell  sarcoma,  the  tumor  most  sensitive  to
poly I:poly  C. As before,  the animals received  poly I:poly C overnight  and
proline-14C  in the morning.  As  shown  in Fig.  4 there was strong  stimulation
of  proline  incorporation  into  the  various  normal  organs.  However,
poly  I:poly  C  treatment  caused  marked  inhibition  of  protein  synthesis  in
the tumor.  This inhibition ranged  from 65 to 95%  in different  experiments.
This inhibition was also seen with two other tumors. It appears reasonable  to
think  that this  inhibition  of protein  synthesis  would  be  inhibitory  to  tumor
900-
FIGURE  4.  Effect of poly I :poly C on  proline incorporation  into various  organs of C57
black mice bearing reticulum cell sarcoma J96132.  Conditions  as for Fig. 3. Ordinate  is
per  cent  enhancement  (+) or  inhibition  (-)  of specific  activity  of organs  from  poly
I :poly C-treated  animals  as compared  with controls.
growth.  It  is possible  however,  that the tumors  had been  damaged  by some
other  mechanism  and  that the decreased  protein  synthesis  is  a reflection  of
this, rather than a cause  of the tumor inhibition.
The effect  of poly I :poly  C  on  RNA metabolism  in tissue  culture  is com-
plex.  Depending  on  dose  and  time,  one  can  observe  inhibition  or  stimula-
tion. There are,  however,  profound  effects  on nuclear RNA  metabolism,  in-
dicating that the effect of the compound  on the  host genome  is much  more
than just  stimulating  the production  of mRNA  for  interferon.The  effect  of
the  compound  on  RNA  metabolism  in  organs  of mice  bearing  the J96132
tumor  is  shown  in  Fig.  5.  In  general,  RNA  synthesis  in  mice  is  affected
somewhat  less  by  poly  I:poly  C  than  is  protein  synthesis.  However,  poly
I:poly  C  treatment  leads  to  a  marked  inhibition  of  RNA  synthesis  in  the
tumor.
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FIGURE  5.  Effect of poly I :poly  C on uridine incorporation  into various organs of C57
black  mice bearing reticulum cell sarcoma J96132.  Conditions as for Fig. 4, except that
50  sCi  uridine-3H  was  used  instead of proline.
The effect  of poly I :poly C on thymidine  incorporation  into DNA can be
either enhancement or inhibition depending on the tissue studied  (Table II).
It  can  be  seen  that  there  is  inhibition  in  primary  mouse  embryo,  rabbit
kidney,  and  Vero  cell  monolayers.  On the other hand,  there  appears  to be
stimulation in L cells, particularly in suspension culture.
A third facet of the antitumor action  of poly  I:poly C  is its  ability to  en-
hance  cell mediated  defense  mechanisms  against  foreign  antigens.  If spleen
cells  from  adult  mice  are  injected  into  newborn  F1 hybrids,  one  of whose
parents  is  the  strain  of the donor  mice,  the donor  cells  develop  a graft  vs.
host reaction  which affects  the recipient  animals  in  a number  of ways  (15).
One  of  these  ways  is  the  establishment  of  a  splenomegaly  in  the recipient
(16,  17).  The degree  of spleen  enlargement  is  a function  of the activity and
the logarithm  of the number  of donor  cells. This test is  useful  in evaluating
immune  suppressive  drugs  and  antilymphocyte  serum.  The depressed  reac-
tivity  of the  spleen  cells  from drug-treated  donor animals  results  in  a lesser
splenomegaly  in  the  recipient  than  that  obtained  from  spleen  cells  from
untreated  donors.  When  donor  mice  are  given  poly  I:poly  C  their  subse-
quently  removed  spleen  cells  show  enhanced  immunological  reactivity
against  the foreign  antigens  in  the recipient  and  result  in  increased  splen-
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TABLE  II
EFFECT  OF POLY  I:  POLY  C ON  THYMIDINE  INCORPORATION
INTO  VARIOUS  CELLS
Incubation
with PIC  Inhibition or
Cells  Monolayer or  spinner  for:  enhancement  Dose
hr  %  #g
L 929 Y  Spinner  3  +24  100
16  +68  25
16  +42  100
L 929 Y  Monolayer  2  No  effect
48  +37  30
96  +32  30
Vero  CCL 81  Monolayer  2  -53  100
16  -34  50
Rabbit kidney  cells  Monolayer  3  No  effect
16  -42  20
P3  cells  (Burkitt)  Suspension  2  -32  25
16  No  effect
Primary mouse  embryo cells  Monolayer  2  No  effect  50
16  -60  50
Cells were  incubated with the indicated  concentration of poly I:  poly C.  Cultures were exposed
for 48 min  to 2.5  c of thymidine-1
4C per  100 ml  of medium.  The cells  were  washed  twice  with
cold  PBS,  suspended  in  cold  10%  TCA  (trichloroacetic  acid),  washed  with 0.1%  cold  TCA,
and hydrolyzed  for 15 min at  100°C in 5% TCA.  Radioactivity  and DNA  concentrations  were
determined  on aliquots  of the hydrolyzate.
omegaly,  as seen in Fig. 6 (18).'  Comparison of the position of the two parallel
lines obtained from injecting different numbers of cells reveals that poly I :poly
C at  1 mg per mouse causes greater  than a tripling of the effectiveness  of the
cells  in  the  graft  vs.  host  reaction,  while  lesser  amounts  of  poly  I:poly  C
produced  a  definite  but  lesser  stimulation.  Enzymatic  hydrolysis  of  the
poly I :poly C destroys its enhancing ability.
It  is reasonable  to think that enhancement  by poly I :poly C  of such  cell-
mediated rejection  of foreign antigens could effectively  act against the foreign
antigens  of  the  tumor,  facilitating  the  rejection  of the  tumor.  Indeed,  the
inhibition  of macromolecule  synthesis  discussed  earlier  may be  a manifesta-
tion of such cellular immunological  activity.  Such enhancement  of immuno-
logical reactivity by polynucleotides  has been observed repeatedly before (19).
It  appears then that there are  at least three  different aspects  of the action
of  poly  I:poly  C  that  bear  on  the  antitumor  activity  of  the  compound:
the activity of the interferon induced,  possible direct chemotherapeutic  action,
and  enhancement  of  immunological  rejection  mechanisms.  The  relative
importance  of  each  of  these  components  and  the  interrelationships  among
Cantor,  H.,  R.  Asofsky,  and  H.  B.  Levy.  Effect  of polyinosinic:  polycytidylic  acid  on  graft vs.
host reaction.  In preparation.
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FIGURE  6.  Effect  of  poly  I:poly  C  on  graft  vs.  host  reaction.  Balb-c  mice  were
inoculated intraperitoneally  with the  indicated  amount  of poly  I :poly  C.  48  hr later
they  were  sacrificed,  and  their  spleens  were  removed  and  minced.  The  indi-
cated  number  of  spleen  cells were  inoculated  into newborn  F  hybrids  of  Balb-c
X  C57  black  mice.  9  days  later  these  animals  and  their  spleens  were  weighed,
and  the  spleen  weight  was  normalized  to  body  weight.  The  spleen  index
is  the  ratio  of  this normalized  spleen  weight  to  the  normalized  spleen  weight  of
animals  not inoculated with spleen cells.
them will be discussed.  Since exogenous interferon  in mice is effective against
some  tumors it  is  obvious  that the  interferon  induced  by  poly  I:poly  C is
important, but it is not understood how interferon inhibits tumors. It  has been
reported  that  interferon  can  inhibit cell  growth  in  tissue  culture  (20),  but
the absence  of such inhibition  has  also been reported  (21,  22).  Since  all  the
testing  has been  done  with  interferons  of varying  degrees  of impurity,  it  is
hard  to exclude  the  possibility  that the  observed  inhibitions  have been due
to impurities. It  may be that in an animal,  interferon treatment increases  the
immune reactivity of the host. We are currently testing this possibility. There
have  been  a  number  of reports  suggesting  a  close  association  between  the
interferon  system and the immunological  systems.  For example, lymphocytes
from  animals  (including  man)  immunized  with  a  specific  antigen  respond,
in  tissue culture,  to  exposure  to  that  antigen  by producing  interferon  (23,
24). 2 Lymphocytes,  on exposure  to  phytohemaglutinin,  change  to  lympho-
blasts, which then produce interferon.  This is the same type of cellular trans-
formation  that occurs when these  cells  are stimulated to produce  antibodies.
It  is possible therefore that there may exist a coordinated relationship  between
initiation of antibody response and initiation of interferon production.
2  Stinebring, W.  Personal communication.
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The ability of poly I :poly  C to enhance cell  mediated  graft vs.  host reac-
tion could  also account for part of its  ability to inhibit the growth of tumors
containing foreign antigens.  It is worth noting that polyadenylic-polyuridylic
acid has been reported  to be as good an  adjuvant  for the production  of cir-
culating  antibodies  as  is  poly  I:poly  C  (25).  However,  poly A:poly U is  a
much poorer inhibitor of tumor growth than poly I :poly C. It remains to be
determined  whether  poly  A:poly  U  enhances  cell  mediated  graft  vs.  host
reactions  as well  as does poly I:poly C.  If it does,  the  implication would  be
that  the  immunological  rejection  mechanisms  may  not  be very  important
in tumor inhibition by poly I :poly C.
Similarly  the  inhibition  of macromolecule  synthesis  observed  in  tumors
of animals treated with poly I :poly C may be attributable  to a direct chemo-
therapeutic  action,  or it may  reflect  the  beginning  of the immune-rejection
mechanisms.  We have seen that by two days  after injection  of poly I:poly C
there  is maximum  stimulation  of  the  graft  rejection  capacity  of the  spleen
cells of the treated animals.  It might indeed  be that the inhibition  of macro-
molecule  synthesis  is just  a reflection  of the  fact  that these  cells  are  dying
from  immune  rejection  mechanisms.  In any  case,  1-2  days  after  initiation
of  treatment  of mice  bearing  the  reticulum  cell  sarcoma  there  is  marked
alteration in the histological  appearance  of the tumor.
The  effect  of poly  I :poly  C  on  chemical  carcinogenesis  may throw  some
light  on  the mechanism  of action  (11).  Dimethylbenzanthracene  (DMBA)
can  be  used  to  induce  tumors  in  mice  by  two  different  procedures.  One
very  small  application  followed  by  repeated  treatments  of  the  skin  with
coton oil will induce skin tumors, or a single application  of a large amount of
DMBA without croton  oil will also  do so.  Poly I :poly  C  almost totally  pre-
vents  the  induction  by  the  DMBA-croton  oil  system  but  only  delays  the
production  of  tumors  induced  by  DMBA  alone.  It  has  been  shown  that
impairment  of  the  host  immunological  processes  will  increase  chemical
carcinogenesis  (26).
Two additional  items are  worth  pointing out  with particular  reference to
the  possible  use  of  poly  I:poly  C  or  interferon  in  the  treatment  of malig-
nancies in man.  One is  the fact that certain  sera hydrolyze  poly I:poly C to
split  products that  are  altered  in  their biological  properties  (27).  The  split
products  no longer have the pyrogenic capability  of the intact poly I :poly C,
they  do  not  induce  interferon  synthesis,3 and  do  not  have  any  antitumor
activity.4 Human  serum  is  one  such  hydrolytic  serum.  This  immediately
poses  the  question  as to  whether  in man  poly I:poly  C  will  be hydrolyzed
before  it  can  act.  There  are  no  data  as  yet  on  this  point  except  that  pre-
3 Baron,  S., and H. B. Levy. Unpublished results.
4 Adamson,  R., J.  Nordlund, S. Wolff,  and H. B. Levy.  Unpublished results.
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liminary evidence, with some other species  of animals which have  hydrolytic
sera, indicates  that poly I:poly C  still can be strongly antiviral.'
The  other  point  of importance  deals  with the  toxicity  of poly I:poly  C.
In  monkeys  and  dogs,  levels  of 3  mg/kg  are  frequently  fatal.6 1 mg/kg  is
reasonably  well  tolerated and  leads to  the production  of low levels  of inter-
feron.  Toxicity  is  associated  with  intravascular  coagulation  in  severe  in-
stances  and with only transient  elevation  of serum  transaminases  and lactic
dehydrogenase  levels  in  mild  instances.  The  levels  that  are  lethal  to  mice
approach  100  mg/kg,  while  levels  that  are  effective  in  antitumor  tests  in
mice  are  5-10  mg/kg.  Nothing  is  known  as  yet about  the  level  that  will
either prove toxic  to man or will induce  interferon  formation.  The capacity
of human serum  to hydrolize  poly I :poly  C may play a role here.
In  summary,  both  interferon  and  synthetic  inducers  of  interferon  have
been  shown to  increase  host survival  time  in mice  and  rats bearing  experi-
mental  tumors.  Studies are currently  underway  in a number of laboratories
to test the possibility that the inducer or exogenous  interferon  may be useful
in  the treatment  of human viral disease  and,  at least for the inducer,  in  the
treatment of malignancy.  Interferon itself may prove to present less of a prob-
lem  with regard  to  toxicity  than  any of the  inducers,  but its  production  in
sufficient  quantities,  in  a  state  sufficiently  pure  for  use  in  man,  may  pose
some  real  difficulties.  The synthetic  inducers  of  interferon,  while  expensive,
are considerably  cheaper than interferon  itself,  but they  do present  greater
problems  of  toxicity.  In  addition  to  which,  the  synthetic  inducers  may
(a)  present  hazards as  yet undetermined,  and  (b)  act by  additional  mecha-
nisms  to  interferon  induction.  Further  investigation  will  certainly  be  re-
quired  before  a  compound  like  polyinosinic-polycytidylic  acid  should  be
used  for  minor  illnesses.  The  treatment  of  a  malignancy  with  nearly  uni-
versally fatal  outcome justifies a greater risk.
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